Picture EBD Group BioPharm Amercia 2022 Boston 650x100px
Document › Details

Carmat S.A.. (4/11/22). "Press Release: Carmat Launches a Capital Increase for an Amount of 30 Million Euros that Has Received Subscription Commitments Totaling 22 Million Euros [NOT FOR RELEASE, EITHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANAD

Organisation Organisation Carmat S.A. (ALCAR)
Products Product Aeson® artificial heart
  Product 2 investment banking
Index term Index term Carmat–SEVERAL: investment, 202204 global offering €40.5m via issuance of 4.05m new shares
Person Person Piat, Stéphane (Carmat 201812 CEO)

Record changed: 2022-04-12


Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

More documents for Carmat S.A. (ALCAR)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BioPharm Amercia 2022 Boston 650x300px

» top